Can we afford to ignore missing data in cost-effectiveness analyses?

The European Journal of Health Economics - Tập 10 - Trang 1-3 - 2008
Andrea Marshall1, Lucinda J. Billingham2, Stirling Bryan3
1Warwick Clinical Trials Unit, University of Warwick, Coventry, Coventry, UK
2Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK
3Health Economics Facility, University of Birmingham, Birmingham, UK

Tài liệu tham khảo

Thông tin
Thông tin xuất bản

The European Journal of Health Economics

Tập 10

1-3

Thông tin tác giả